Nasus Pharma Ltd Convertible Debt, Current
Nasus Pharma Ltd (NSRX) had Convertible Debt, Current of $2.56 million as of 2025-06-30, per its 6-K filed 2025-12-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ConvertibleDebtCurrent · last filed 2026-03-25
- 2025-06-30: Convertible Debt, Current $2.56M.
- 2024-12-31: Convertible Debt, Current $1.80M.
| Period end | Convertible Debt, Current |
|---|---|
| 2025-06-30 | $2.56M 6-K · filed 2025-12-29 |
| 2024-12-31 | $1.80M 20-F · filed 2026-03-25 |